Conférences  >  Médecine & Soins de Santé  >  Maladies Infectieuses

Harvard Medical School

This comprehensive Harvard Medical School CME program—one of the highest-rated HMS CME courses—ensures attendees are current with state-of-the-art approaches to prevention, detection, diagnosis and treatment of infectious diseases. Updates, best practices and new guidelines are presented by nationally recognized ID experts and master clinicians. Education is practical and results driven: Optimal decision-making in the prevention, diagnosis, and treatment of infectious diseases; Newer antimicrobials and treatment strategies for highly resistant infections; The latest on COVID-19, including long COVID; Prevention and treatment of infection in immunocompromised hosts; Update on antifungal diagnostics and therapy; State-of-the-art and multidisciplinary approaches to common infections; Clinical approaches to complex, rare, and "don't-miss" infections; Infections in persons with substance use disorder; What’s new in HIV prevention and management; New, evolving, emerging, and re-emerging infectious diseases. As revised treatment strategies, new diagnostic tests, and guidelines are presented, they are coupled with specific recommendations for incorporating these updates into your day-to-day work.

Harvard Medical School Postgraduate Medical Education;     Tél.: [617-384-8600];     Email.: CEPrograms@hms.harvard.edu

Harvard, infection, comprehensive, CME, immunocompromised, antifungal, HIV, resistant infection, antimicrobial stewardship, substance use disorder, emerging infectious diseases, zoonoses, tick-borne, ENT, Vaccine, Vaccination, sexually transmitted infections, Hepatitis, MRSA, OPAT, COVID, COVID-19, STIs, difficile, C-diff, staph, PEP, PrEP, CNS, skin, soft tissue, Rift Valley Fever, Polio, Bronchiectasis, pneumonia, non-tuberculous mycobacteria

Système de santé, gestion hospitalière,    Législation en médecine et pharmacologie

Foster Research

On behalf of Foster Research Organizing Committee, we are delighted to invite you over a three-day “Global Research Conference on Emerging Infectious Diseases” (GRCEID2024) scheduled to take place on August 29- 31, 2024 in Kuala Lumpur, Malaysia, promises to be an exceptional event for researchers, scientists, and healthcare professionals. This conference aims to bring together experts from around the globe to discuss about the Emerging Infectious Diseases, the leading cause of death worldwide, continue to pose difficult challenges to clinicians, public health professionals, and biomedical researches in academic settings and industry.

Conference Secretary;     Tél.: [9100067998];     Email.: sowmyafosterresearch@gmail.com

In the last years, there is a great concern about the problem of bacterial resistance to antibiotics used in human medicine as well as in veterinary. The use of antibiotics constitutes an important factor for selection of resistance, not only among pathogenic bacteria but also among the commensal ones. Antimicrobial resistance is a major problem in public health due to the possibility in therapeutic failure. The primary objective of this meeting is to bring together researchers involved in antibiotic resistance prevention and control. The meeting will take an integrated approach to research and it will bring about researchers specializing in different subjects related to antibiotic resistance. We expected to present a universal vision of the importance of antimicrobial resistance in different ecosystems and what can be done about it.

Pharmacologie et développement des médicaments,    Épidémiologie

Ashfield Medcomms

HIV Glasgow will take place between 10-13 November 2024 both as an in-person and a virtual meeting. As in previous years, the programme will be of interest to clinical investigators from across the globe to review current research and discuss its implications for HIV management strategies. Although there have been significant advances in treatment, new challenges have now appeared. This Congress has moved into areas beyond treatment to look at prevention and cure. The role of people living with HIV in treatment decisions and self-management will feature and we look forward to perspectives in the programme from the community.

Event Secretariat;     Email.: hivglasgow@ashfieldmedcomms.com

HIV, Drug Therapy, Infectious Diseases

EMBL Heidelberg

Infectious diseases are among the most prevalent causes of human illness and death in the world. Pathogens infect humans and all life forms on Earth, being able to cross species barriers, thereby adversely impacting human and planetary health. Fundamental research in infection biology is urgently needed to find therapies for longstanding and emerging infectious diseases. The EMBL Conference ‘The next generation in infection biology’ is a platform for late-stage postdoctoral scientists in the field of infection biology to present their work and connect with the leading European institutions in infection biology. The speakers will be chosen for their track record of research accomplishments and their high-reaching future plans. The audience will have the unique opportunity to experience cutting-edge science presented by the rising leaders in this field. The institutional partners will provide discussion and networking opportunities to connect and shape the future league of infection biologists in Europe.

EMBL Events;     Email.: events@embl.de

LInfectionBiology